Cell differentiation inducer, benzamide compounds
USRE40703E1 · kind E1 · reissue
1Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2006 |
| Grant date | Apr 28, 2009 |
| Priority date | — |
| Expiry date | Oct 3, 2026 |
Classification
- Technology area (CPC —)General
Abstract
The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.